Ncats is in need of custom synthesis and bioanalytical services in internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases
Ended Purchase Order Awarded Last action
- Contract number
- 75N95024P00604
- Awardee
-
Chemogenics Biopharma, LLC UEI MQLWQEJKQLR3
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $240,000
Award facts
- Opportunity
-
- Synthesis and bioanalytical analysis of f small molecules for the NCATS Early Translational Branch Chemistry Program Solicitation · 75N95024Q00563 · Posted Aug 30, 2024
- Contract value 100% obligated
- $240,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 541380 Testing Laboratories and Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27707, USA
Award details come from SAM.gov/FPDS.
About this award
The National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) awarded a $240,000.00 firm fixed-price purchase order to Chemogenics Biopharma, LLC, a for-profit limited liability company, for custom synthesis and bioanalytical services to support NCATS' internal projects focused on developing small molecule inhibitors of physiological small molecule methyltransferases. The 12-month contract is not set aside and is awarded under FAR Part 13 simplified acquisition procedures. Chemogenics Biopharma has previously performed similar work for NCATS and other NIH institutes under prior purchase orders.
Quick answers
Who was awarded contract 75N95024P00604?
75N95024P00604 was awarded to Chemogenics Biopharma, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 16, 2024.
How much is contract 75N95024P00604 worth?
The government has obligated $240,000 on 75N95024P00604.
Which agency awarded contract 75N95024P00604?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024P00604, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Was contract 75N95024P00604 competed?
The extent of competition for 75N95024P00604 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award